Kazumasa Takenaka

Fujita Health University — Japan

Medicine · Health Sciences

29h-index1.9kcitations114works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Drug Transport and Resistance Mechanisms(19), Peptidase Inhibition and Analysis(13), HIV/AIDS drug development and treatment(12), Lung Cancer Treatments and Mutations(10), Cholangiocarcinoma and Gallbladder Cancer Studies(10)

Publications114 total

Statins attenuate PD-L1 sorting to small extracellular vesicles dependent on ubiquitin-like 3 modification
Scientific Reports·2025Open Access
A Case of Erythema Nodosum Associated with Granulomatous Mastitis
The Nishinihon Journal of Dermatology·2025Open Access
Clinical Study of 63 Cases of Snakebite by MAMUSHI
The Nishinihon Journal of Dermatology·2025Open Access
A Case of Pyoderma Gangrenosum During Nivolumab Treatment for Right Upper Lobe Lung Cancer
The Nishinihon Journal of Dermatology·2024Open Access
Supplementary Figure Legends from Administration of PLK-1 small interfering RNA with atelocollagen prevents the growth of liver metastases of lung cancer
2023Open Access
Supplementary Fig. S2 from Administration of PLK-1 small interfering RNA with atelocollagen prevents the growth of liver metastases of lung cancer
2023Open Access
Supplementary Fig. S1 from Administration of PLK-1 small interfering RNA with atelocollagen prevents the growth of liver metastases of lung cancer
2023Open Access
Data from Administration of PLK-1 small interfering RNA with atelocollagen prevents the growth of liver metastases of lung cancer
2023Open Access
Supplementary Fig. S2 from Administration of PLK-1 small interfering RNA with atelocollagen prevents the growth of liver metastases of lung cancer
2023Open Access
Supplementary Fig. S1 from Administration of PLK-1 small interfering RNA with atelocollagen prevents the growth of liver metastases of lung cancer
2023Open Access
Supplementary Figure Legends from Administration of PLK-1 small interfering RNA with atelocollagen prevents the growth of liver metastases of lung cancer
2023Open Access
Data from Administration of PLK-1 small interfering RNA with atelocollagen prevents the growth of liver metastases of lung cancer
2023Open Access
Supplementary Methods, Figure Legends 1-3 from Deoxycytidine Kinase Modulates the Impact of the ABC Transporter ABCG2 on Clofarabine Cytotoxicity
2023Open Access
Supplementary Table 1 from Substrate Overlap between Mrp4 and Abcg2/Bcrp Affects Purine Analogue Drug Cytotoxicity and Tissue Distribution
2023Open Access
Supplementary Figure 1 from Transporter-Mediated Protection against Thiopurine-Induced Hematopoietic Toxicity
2023Open Access
Supplementary Figure 3 from Deoxycytidine Kinase Modulates the Impact of the ABC Transporter ABCG2 on Clofarabine Cytotoxicity
2023Open Access
Supplementary Figure 1 from Deoxycytidine Kinase Modulates the Impact of the ABC Transporter ABCG2 on Clofarabine Cytotoxicity
2023Open Access
Supplementary Figure 2 from Deoxycytidine Kinase Modulates the Impact of the ABC Transporter ABCG2 on Clofarabine Cytotoxicity
2023Open Access
Data from Substrate Overlap between Mrp4 and Abcg2/Bcrp Affects Purine Analogue Drug Cytotoxicity and Tissue Distribution
2023Open Access
Supplementary Figure 1 from Substrate Overlap between Mrp4 and Abcg2/Bcrp Affects Purine Analogue Drug Cytotoxicity and Tissue Distribution
2023Open Access
page 1 of 6Next →

Frequent Co-authors

Fumihiro Tanaka(24), Hiromi Wada(23), Kazuhiro Yanagihara(12), Yosuke Otake(11), Ryo Miyahara(9), Hiromichi Katakura(9), Eiji Ogawa(8), Shinya Ishikawa(7), Yozo Kawano(7), Masashi Adachi(7), Makoto Sonobe(7), Shinjiro Nagai(6), K Sugimachi(6), John D. Schuetz(5), K Shirabe(5), Kiyoshi Kajiyama(4), Tomonobu Gion(4), Hiroki Oyanagi(4), Masatsugu Nakagawa(3), Yoshihiro Koshino-Kimura(3)